(Q40736593)

23 September 2017

title

Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors (English)

1 reference

23 September 2017

Terrence L Fisher

1

1 reference

23 September 2017

MaryAnn Nocera

2

1 reference

23 September 2017

Richard A Willis

3

1 reference

23 September 2017

Michael J Turner

4

1 reference

23 September 2017

C Siddiq Abdul Alim

5

1 reference

23 September 2017

Deborah M Brown

6

1 reference

23 September 2017

Patricia A Bourne

7

1 reference

23 September 2017

P Anthony di Sant'Agnese

8

1 reference

23 September 2017

Edward M Messing

9

1 reference

23 September 2017

Edith M Lord

10

1 reference

23 September 2017

John G Frelinger

11

1 reference

23 September 2017

publication date

1 May 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

51

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

153-165

1 reference

The new human kallikrein gene family: implications in carcinogenesis

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Serological identification of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Matrix metalloproteinases: multifunctional contributors to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Preclinical and clinical studies of MMP inhibitors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

The IGF axis in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

A freezing method for cell fusions to distribute and reduce labor and permit more thorough early evaluation of hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Uncoupling of ATP binding to Na+,K+-ATPase from its stimulation of ouabain binding: studies of the inhibition of Na+,K+-ATPase by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Monoclonal antibodies to human pancreatic trypsin 1 inhibit the activation of human trypsinogens 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Structural and functional influence of enzyme-antibody interactions: effects of eight different monoclonal antibodies on the enzymatic activity of Escherichia coli tryptophan synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

?-Galactosidase: Immune recognition of conformation and mechanism of antibody-induced catalytic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10071

21 January 2018

Identifiers

DOI

10.1002/PROS.10071

1 reference

23 September 2017

1 reference